Seller comparison · US self-pay prices

MEDVi vs CoreAge Rx: GLP-1 Prices Compared

MEDVi and CoreAge Rx both sell compounded semaglutide injection and compounded tirzepatide injection. Compounded semaglutide injection: not ranked against each other, because neither price states the supply period it buys: MEDVi advertises $199/mo, CoreAge Rx from $79/mo. The lower advertised figure is CoreAge Rx's. Compounded tirzepatide injection: not ranked against each other, because neither price states the supply period it buys: MEDVi advertises $299/mo, CoreAge Rx from $129/mo. The lower advertised figure is CoreAge Rx's. Both sell only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. Prices checked Nov 4, 2026.

Compare all 4 offersMEDVi pricesCoreAge Rx prices

Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Each seller's lowest price now

  • Lowest price, compounded and not FDA-approved

    MEDVi

    $199/mo

    View

  • Lowest price, compounded and not FDA-approved

    CoreAge Rx

    from $79/mo

    View
Same product

What MEDVi and CoreAge Rx charge for the same medication

Entry prices first, then the published top-dose price where either seller states one. Each price links the seller's own page.

Compounded semaglutide injection

Entry price: not ranked against each other, because neither price states the supply period it buys: MEDVi advertises $199/mo, CoreAge Rx from $79/mo. The lower advertised figure is CoreAge Rx's. Top dose: only CoreAge Rx publishes a top-dose price here: from $79/mo at 2.4 mg.

MEDVi

Advertised entry price

$199/mo

Supply period unverified; excluded from cost ranking.

Checked

Compounded semaglutide via MEDVi

MEDVi · Sourced provider quote

refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

Price conditions

refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

View offer

Published maintenance dose

No dose-specific quote tracked.

CoreAge Rx

Advertised entry price

from $79/mo

Supply period unverified; excluded from cost ranking.

Checked

Compounded semaglutide via CoreAge Rx

CoreAge Rx · Sourced provider quote

starting self-pay rate; no membership fee

Price conditions

starting self-pay rate; no membership fee

The product page states no long-term contracts, free delivery and no membership fees; the site header advertises semaglutide from $99/mo, the product page from $79. No supply length is stated. CoreAge's FAQ says all doses cost the same: the price locked in at checkout stays the same regardless of dose increases. Compounded; not FDA-approved.

View offer

Published maintenance dose

from $79/mo

Supply period unverified; excluded from cost ranking.

Checked

At 2.4 mg

Compounded semaglutide via CoreAge Rx

CoreAge Rx · Sourced provider quote

starting self-pay rate; no membership fee

Price conditions

starting self-pay rate; no membership fee

The product page states no long-term contracts, free delivery and no membership fees; the site header advertises semaglutide from $99/mo, the product page from $79. No supply length is stated. CoreAge's FAQ says all doses cost the same: the price locked in at checkout stays the same regardless of dose increases. Compounded; not FDA-approved.

The seller states one price at every dose, so this is also its price at 2.4 mg.

View offer

Compounded tirzepatide injection

Entry price: not ranked against each other, because neither price states the supply period it buys: MEDVi advertises $299/mo, CoreAge Rx from $129/mo. The lower advertised figure is CoreAge Rx's. Top dose: not ranked against each other, because neither price states the supply period it buys: MEDVi advertises $299/mo at 15 mg, CoreAge Rx from $129/mo at 15 mg. The lower advertised figure is CoreAge Rx's.

MEDVi

Advertised entry price

$299/mo

Supply period unverified; excluded from cost ranking.

Checked

Compounded tirzepatide via MEDVi

MEDVi · Sourced provider quote

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription

Price conditions

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription

Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

View offer

Published maintenance dose

$299/mo

Supply period unverified; excluded from cost ranking.

Checked

At 15 mg

Compounded tirzepatide via MEDVi

MEDVi · Sourced provider quote

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription

Price conditions

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription

Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

The seller states one price at every dose, so this is also its price at 15 mg.

View offer
CoreAge Rx

Advertised entry price

from $129/mo

Supply period unverified; excluded from cost ranking.

Checked

Compounded tirzepatide via CoreAge Rx

CoreAge Rx · Sourced provider quote

starting self-pay rate; no membership fee

Price conditions

starting self-pay rate; no membership fee

The product page states no long-term contracts, free delivery and no membership fees. No supply length is stated. CoreAge's FAQ says all doses cost the same: the price locked in at checkout stays the same regardless of dose increases. Compounded; not FDA-approved.

View offer

Published maintenance dose

from $129/mo

Supply period unverified; excluded from cost ranking.

Checked

At 15 mg

Compounded tirzepatide via CoreAge Rx

CoreAge Rx · Sourced provider quote

starting self-pay rate; no membership fee

Price conditions

starting self-pay rate; no membership fee

The product page states no long-term contracts, free delivery and no membership fees. No supply length is stated. CoreAge's FAQ says all doses cost the same: the price locked in at checkout stays the same regardless of dose increases. Compounded; not FDA-approved.

The seller states one price at every dose, so this is also its price at 15 mg.

View offer

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss

Every sourced offer

All MEDVi and CoreAge Rx offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

4 offers · US self-pay

This order is by the number alone, with no referral input. Partner links may earn us a referral fee.

  • Compounded semaglutide via CoreAge Rx

    Semaglutide · Compounded

    Compounded · Not FDA-approved
    CoreAge Rx
    Advertised pricefrom $79/mo

    Supply period unverified; excluded from cost ranking.

    Checked

    Maintenance pricefrom $79/mo

    At 2.4 mg

    Supply period unverified; excluded from cost ranking.

    Checked

    View offer
    Price conditions & source

    Advertised price: starting self-pay rate; no membership fee

    Maintenance terms: The seller states one price at every dose, so this is also its price at 2.4 mg.

    The product page states no long-term contracts, free delivery and no membership fees; the site header advertises semaglutide from $99/mo, the product page from $79. No supply length is stated. CoreAge's FAQ says all doses cost the same: the price locked in at checkout stays the same regardless of dose increases. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (coreagerx.com)
  • Compounded semaglutide via MEDVi

    Semaglutide · Compounded

    Compounded · Not FDA-approved
    MEDVi
    Advertised price$199/mo

    Supply period unverified; excluded from cost ranking.

    Checked

    Maintenance price

    No separate dose price verified

    View offer
    Price conditions & source

    Advertised price: refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

    Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (glp1.medvi.org)
  • Compounded tirzepatide via CoreAge Rx

    Tirzepatide · Compounded

    Compounded · Not FDA-approved
    CoreAge Rx
    Advertised pricefrom $129/mo

    Supply period unverified; excluded from cost ranking.

    Checked

    Maintenance pricefrom $129/mo

    At 15 mg

    Supply period unverified; excluded from cost ranking.

    Checked

    View offer
    Price conditions & source

    Advertised price: starting self-pay rate; no membership fee

    Maintenance terms: The seller states one price at every dose, so this is also its price at 15 mg.

    The product page states no long-term contracts, free delivery and no membership fees. No supply length is stated. CoreAge's FAQ says all doses cost the same: the price locked in at checkout stays the same regardless of dose increases. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (coreagerx.com)
  • Compounded tirzepatide via MEDVi

    Tirzepatide · Compounded

    Compounded · Not FDA-approved
    MEDVi
    Advertised price$299/mo

    Supply period unverified; excluded from cost ranking.

    Checked

    Maintenance price$299/mo

    At 15 mg

    Supply period unverified; excluded from cost ranking.

    Checked

    View offer
    Price conditions & source

    Advertised price: monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription

    Maintenance terms: The seller states one price at every dose, so this is also its price at 15 mg.

    Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (glp1.medvi.org)

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.

The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of October 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. The default order of a list is by price, lifted by a referral boost for the sellers that pay us, and says so beside the list; every lowest-cost sort reads the price alone. Every partner is labeled. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. The default order of a list is by price, lifted by a referral boost for the sellers that pay us, and says so beside the list; every lowest-cost sort reads the price alone. Every partner is labeled. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

Public record

MEDVi vs CoreAge Rx: reviews, BBB and FDA

What Trustpilot, the BBB and the FDA say about each. These records do not measure medical quality or results.

MEDVi

Trustpilot 4.3 from 15,227 reviews. The BBB rates MEDVi F, with 789 complaints filed in the last 3 years. It is not BBB accredited. The FDA sent MEDVi a warning letter (Feb 20, 2026) about claims on its website.

Is MEDVi legit?

CoreAge Rx

No Trustpilot profile found. The BBB rates CoreAge Rx F. It is not BBB accredited. We found no FDA warning letter naming CoreAge Rx as of Nov 6, 2026.

Is CoreAge Rx legit?
Questions

MEDVi vs CoreAge Rx: common questions

Is MEDVi or CoreAge Rx cheaper for GLP-1 medication?

Compounded semaglutide injection: not ranked against each other, because neither price states the supply period it buys: MEDVi advertises $199/mo, CoreAge Rx from $79/mo. The lower advertised figure is CoreAge Rx's. At the top published dose, only CoreAge Rx publishes a top-dose price here: from $79/mo at 2.4 mg. Compounded tirzepatide injection: not ranked against each other, because neither price states the supply period it buys: MEDVi advertises $299/mo, CoreAge Rx from $129/mo. The lower advertised figure is CoreAge Rx's. At the top published dose, not ranked against each other, because neither price states the supply period it buys: MEDVi advertises $299/mo at 15 mg, CoreAge Rx from $129/mo at 15 mg. The lower advertised figure is CoreAge Rx's. Prices are the sellers' own advertised self-pay prices, with the conditions listed beside each.

Do MEDVi and CoreAge Rx sell FDA-approved GLP-1s or compounded versions?

Both sell only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do MEDVi and CoreAge Rx prices include?

MEDVi, compounded semaglutide injection: $199/mo, refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract. CoreAge Rx, compounded semaglutide injection: from $79/mo, starting self-pay rate; no membership fee. MEDVi, compounded tirzepatide injection: $299/mo, monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription. CoreAge Rx, compounded tirzepatide injection: from $129/mo, starting self-pay rate; no membership fee.

When were MEDVi and CoreAge Rx prices last checked?

Prices checked Nov 4, 2026. Each quote links the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

Seller pages re-read automatically : 4 of 4 opened and checked for price changes. How prices stay current

Updated automatically

MEDVi and CoreAge Rx price changes

Written from each source's own record as it changes. Every change on GLPcompare

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.